EV-miR-146a from multiple myeloma (MM) cells is transferred to MSCs and increases the expression and secretion of cytokines, including IL-6, CXCL1, IP-10, and CCL5 by activating Notch pathway, which further promotes the viability and migration of MM cells [162]. Here, CXCL1 is linked to Miyoshi myopathy.